Merck's HPV vaccine gets China approval for men

Merck's HPV vaccine gets China approval for men amid declining sales
Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a much-needed boost in a key market where demand has been falling among women.
China administers its first dose of HPV vaccine for men
The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV vaccine, after US pharmaceutical giant Merck announced its quadrivalent HPV vaccine Gardasil had been approved for additional indications by the National Medical Products Administration.
China's first HPV vaccine for men approved for market
The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products Administration, becoming the first and only HPV vaccine authorized for use in men in China,
Merck says HPV vaccine for men approved by China's drug regulator
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's medical products administration, providing a much-needed boost to the company in a key market.
HPV vaccine for males approved in China
US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator.
Merck Gets China Nod on HPV Shot for Men Amid Sales Slump
China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the US drug giant after a rush among women to get the shot lost steam.
Merck’s Gardasil receives expanded approval for males in China
Merck (MRK) announced that the National Medical Products Administration of China approved Gardasil Vaccine for use in males 9-26 years of age
hMPV is spreading in China. Here’s what to know about this virus
Five years after the first cases of COVID-19, reports of hMPV, an obscure respiratory virus in China may understandably raise ...
Rising HMPV cases in China are ‘what we would expect to see’ in winter, health officials say
As China experiences a rise in respiratory infections this winter, one little-known virus has gotten a lot of attention – and ...
China's WuXi Biologics to sell Irish vaccine facility to Merck for $500 million
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
What you need to know about HMPV as China sees rise in cases
As China continues to monitor an increase in cases of human metapneumovirus (HMPV), here's what you need to know about the ...
How worried should you be about the HMPV outbreak in China?
Professor Paul Hunter from the University of East Anglia notes that almost every child contracts HMPV by five years of age, ...
China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
HMPV cases in India: How is it different from COVID-19? From symptoms to vaccine — Key facts to know
The fear over the spread of HMPV virus that led to concerns if it will trigger Covid-19-like health emergency. Is HMPV same ...